Detection of fungal sequences in human brain: rDNA locus amplification and deep sequencing

Rodrigo Leitao1, Iam Ut Wan2, Harry Chown2

  • 1MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, W12 0BZ, UK. r.monteirinho-leitao@imperial.ac.uk.

Scientific Reports
|December 31, 2024
PubMed

Insights

Fungal infections may play a role in neurodegenerative diseases like Alzheimer's disease (AD) and Parkinson's disease (PD). Researchers used nanopore sequencing to detect fungal DNA in brain tissue and cerebrospinal fluid (CSF).

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Genomics

Background:

  • Alzheimer's disease (AD) and Parkinson's disease (PD) are neurodegenerative disorders of unknown etiology, characterized by neuroinflammation.
  • While bacterial and viral links are explored, fungal infection's role in AD/PD remains under-investigated.

Purpose of the Study:

  • To investigate the presence of fungal genera in human brain tissue and cerebrospinal fluid (CSF) from patients with neurodegenerative diseases.
  • To explore a potential link between fungal infections and the pathogenesis of AD and PD.

Main Methods:

  • Utilized nanopore-based sequencing for high-throughput characterization of microbial DNA.
  • Analyzed human brain tissue and CSF samples.

Main Results:

  • Detected small fungal DNA burdens in two Alzheimer's disease (AD) brains.
  • Identified fungal DNA in one control case with extensive amyloid angiopathy.

Conclusions:

  • The nanopore sequencing approach is suitable for detecting fungal presence in neurological samples.
  • Further research is warranted to establish a definitive link between fungal infections and neurodegenerative diseases like AD and PD.